Comparative Efficacy of Treatments for Brain Metastases from Non–Small Cell Lung Cancer without an EGFR-Mutation/ALK-Rearrangement: A Systematic Review and Network Meta-Analysis-Reference-Cited by-同舟云学术

Comparative Efficacy of Treatments for Brain Metastases from Non–Small Cell Lung Cancer without an EGFR-Mutation/ALK-Rearrangement: A Systematic Review and Network Meta-Analysis

Published:2022-02 Issue: Volume:158 Page:e87-e102
ISSN:1878-8750
Container-title:World Neurosurgery
language:en
Short-container-title:World Neurosurgery

Author:

Brar Karanbir^ORCID,Taslimi Shervin,Ellenbogen Yosef,Deng Jiawen^ORCID,Hou Winston,Moraes Fabio Y.,Glantz Michael,Zacharia Brad E.,Tan Aaron^ORCID,Ahluwalia Manmeet S.,Khasraw Mustafa,Zadeh Gelareh,Mansouri Alireza

Publisher

Elsevier BV

Subject

Neurology (clinical),Surgery

Reference53 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Central nervous system tumors;Ashby;Update Cancer Therapeut,2006

3. The management of brain metastases in non–small cell lung cancer;Owen;Front Oncol,2014

4. The changing paradigm of treatment for non–small cell lung cancer intracranial metastases;Azzam;Curr Pulmonol Rep,2018

5. Prevalence and natural history of ALK positive non–small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors;Chia;Clin Epidemiol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Metastasis of Non-small Cell Lung Cancer After Disease-Free Survival of 5 years: Case Series and Comprehensive Literature Review;World Neurosurgery;2024-06

2. RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis;Frontiers in Oncology;2022-11-28

3. Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis;Frontiers in Oncology;2022-04-04